Fadogia Agrestis

Genuinely unknown. The clinical evidence base for Fadogia agrestis in humans is essentially non-existent — no randomized controlled trials, no systematic safety studies, no pharmacokinetic data in human subjects. The testosterone-elevating claim derives almost entirely from two short-term rodent studies by Yakubu et al. (2005, PMID: 15832054; 2008, PMID: 18602774), which showed dramatic serum testosterone elevation in male rats given Fadogia stem extract at 50-100 mg/kg daily for 5 days. Whether this effect translates to humans at typical supplement doses is genuinely unknown. Caveats to the rodent data: (1) species differences in steroid metabolism and testicular response are unpredictable; (2) the doses used would extrapolate to ~7-15 mg/kg in humans (500-1100mg for a 75kg person), which is at or above commercial product dosing; (3) the same research group documented liver, kidney, and testicular toxicity in rats at similar doses (Yakubu 2008, PMID: 19042951); (4) short-term rodent studies rarely predict long-term effects in humans. Anecdotal reports on Reddit and podcast-amplified testimonials are not substitutes for clinical trial evidence — they reflect placebo effects, expectation bias, confounding from other stack components, and selection bias. Honest bottom line: you might be taking an effective testosterone supplement, you might be taking an expensive placebo, or you might be taking something actively harmful — human data cannot distinguish these possibilities yet.

Primarily through Dr. Andrew Huberman's podcast recommendation starting around 2021-2022. Huberman, a Stanford neuroscientist with one of the most-listened podcasts globally, discussed Fadogia agrestis (typically paired with Tongkat Ali) as part of his personal testosterone-support regimen. The Huberman endorsement produced a rapid supply-and-demand surge: prior to 2021, Fadogia was essentially absent from Western supplement shelves; by 2023, dozens of brands offered Fadogia products. This is a notable case study in how modern podcast and social-media-driven supplement culture can catapult an obscure compound from ethnomedical obscurity to mass-market availability in under two years — often with dramatically thinner supporting evidence than the mainstream audience appreciates. The Huberman endorsement itself is based on the Yakubu rat studies (PMID: 15832054, 15999169) rather than human clinical evidence. This doesn't mean Fadogia is necessarily ineffective or unsafe — it means that its widespread use substantially outpaces its evidence base, and users should recognize they're participating in an informal mass self-experiment rather than using a well-characterized supplement.

The honest answer: we don't really know in humans. Rodent toxicology studies from the same research group that showed testosterone-elevating effects (Yakubu et al. 2008, PMID: 19042951) documented significant dose-dependent toxicity at comparable doses, including hepatic injury, renal injury, and testicular damage. Whether analogous toxicity occurs in humans at commonly used supplement doses is unknown. Anecdotal reports from Reddit and supplement forums include GI disturbance, headaches, sleep disturbance, anxiety, and mood changes. Rare but concerning reports include liver function abnormalities, though causality is hard to establish in users taking multiple supplements. Reasonable precautions for Fadogia users: (1) Baseline comprehensive metabolic panel and hormone panel before starting; (2) Follow-up labs during use to monitor liver and kidney function; (3) Strict cycling — 4-8 weeks on, 4+ weeks off; (4) Avoid stacking with other hepatotoxic or nephrotoxic herbs/medications; (5) Discontinue at the first sign of hepatic or renal dysfunction; (6) Avoid entirely if you have existing liver disease, kidney disease, or hormone-sensitive conditions. The 'probably safe' inference from Fadogia's traditional West African use is weak — traditional use was likely not chronic daily supplementation at commercial extract doses, and traditional medicine contexts don't prospectively monitor for rare adverse events.

These three herbs are often grouped as 'natural testosterone support' options, but their evidence bases are substantially different: Tongkat Ali has the strongest human clinical evidence — multiple randomized controlled trials (Tambi 2012 PMID: 21671978, Talbott 2013 PMID: 23754037, George 2014, Henkel 2014) demonstrating SHBG reduction, free testosterone elevation, cortisol reduction, and symptomatic improvement in men with low-normal testosterone. Safety well-characterized at 200-400mg/day of standardized extracts. Tribulus terrestris has inconsistent human evidence — null results for testosterone in healthy young men (Neychev 2005 PMID: 16174439, Antonio 2000 PMID: 10861337, Rogerson 2007 PMID: 17530942) but some positive findings for sexual function in women with HSDD (Akhtari 2014 PMID: 24773615) and men with ED (Gama 2014 PMID: 25006676, Kamenov 2017 PMID: 28389034). Testosterone effects in healthy men largely absent; libido effects genuine. Fadogia agrestis has essentially zero human clinical evidence — only rodent studies, with a worrying rodent toxicity signal, and no characterized active compounds. If you're choosing ONE natural testosterone support supplement based on evidence, choose Tongkat Ali. If you're experimentally stacking, Tongkat Ali should be the foundation, with Fadogia as a speculative addition cycled more aggressively. Tribulus provides libido benefits but not testosterone benefits in healthy men.

Genuinely uncertain. Commercial products typically provide 400-600mg of stem extract daily; some go up to 1000mg/day. Rodent studies showed effects at 50-100 mg/kg, which extrapolates to approximately 500-1100mg for a 75kg person. However: (1) human pharmacokinetics and response are unknown, (2) 'extract ratio' variations between products make mg comparisons unreliable, (3) the rodent toxicity occurred at the same doses that produced testosterone elevation. Reasonable approach: Start at 300-400mg daily for the first 1-2 weeks to assess tolerance. If tolerated and no benefits after 4 weeks, discontinue rather than escalating. If tolerated and subtle benefits, can increase to 500-600mg. Doses above 800mg/day are not recommended given the rodent toxicity signal. Cycling is important — 4-8 weeks on, 4+ weeks off. Morning dosing with food is preferred. Most users tolerate the lower end of commercial dosing better than the upper end. Higher doses are not clearly more effective and may increase adverse effect risk. 'More is better' is a common supplement myth that does not apply to Fadogia; if the compound doesn't work at moderate doses, escalating is more likely to produce toxicity than additional benefit.

Unclear, because 'working' has not been clearly demonstrated in humans. Anecdotal reports suggest: (1) Subjective libido and energy effects often reported within days to 2 weeks; (2) Purported hormone changes (if they occur) likely require 3-4+ weeks to become measurable; (3) Training performance and body composition effects (if they occur) would take 8+ weeks to become apparent; (4) Negative effects (sleep disturbance, mood changes, GI issues) often appear within the first 1-2 weeks. Cyclical approach: a reasonable 8-week on cycle should make any genuine effects apparent. If you notice nothing meaningful after 4-6 weeks of consistent use at appropriate doses, you're probably not going to notice anything — discontinue rather than extending. If you notice subtle positive changes, continue the cycle but recognize that placebo effects operate on similar timelines. The most informative single experiment for an individual user would be a 'washout then rechallenge' — use for 6-8 weeks, take 4-6 weeks off, then restart: if benefits clearly wane during off-cycle and return with restart, the compound is probably doing something; if nothing changes during off-cycle, it may not have been doing anything measurable.

Yes, this is the most famous Fadogia stack — popularized by Dr. Andrew Huberman as his personal testosterone support combination. The logic: different mechanisms are theoretically complementary. Tongkat Ali appears to work primarily by reducing sex hormone binding globulin (SHBG) and cortisol, increasing free testosterone from existing total testosterone without necessarily changing total testosterone (Tambi 2012 PMID: 21671978). Fadogia purportedly works by stimulating testosterone production through HPG axis activation (based on rat data). Combining could theoretically produce additive benefits. Practical protocol: Tongkat Ali 200mg daily (LJ100 or Physta standardized extracts) as the foundation given stronger evidence and better safety profile; Fadogia 400-600mg daily cycled aggressively (8 weeks on, 4 weeks off, or more cautious). Tongkat Ali can be continued year-round; Fadogia should be cycled. Important: stacking doesn't escape the Fadogia evidence gaps — you're still taking a supplement with no human clinical evidence, just alongside one that does have evidence. The Tongkat Ali component is doing the evidence-supported work; Fadogia is the speculative adjunct. Monitor labs and discontinue if any concerns emerge. Many users report that after trying the stack and then running just Tongkat Ali, they can't clearly distinguish the effects — suggesting Tongkat Ali may be the primary functional ingredient.

Very little data exists, and the risk/benefit for women is unfavorable. Fadogia is primarily studied (in rats) as an androgenic / testosterone-elevating compound. For most women, elevating testosterone is either not desirable (could produce androgenic side effects like acne, hair thinning, voice changes, hirsutism) or carries specific clinical concerns (PCOS patients typically have elevated androgens already). Potential legitimate use cases for women: (1) Post-menopausal women with hypoactive sexual desire disorder — testosterone supplementation can be clinically indicated in this group, but medical testosterone therapy has better evidence than Fadogia; (2) Certain clinical contexts with documented low androgens — again, clinical treatment is preferred over herbal experimentation. For women considering Fadogia despite these caveats: use lower doses than men (100-200mg rather than 400-600mg), monitor for androgenic side effects, cycle aggressively (4 weeks on / 4 weeks off), obtain baseline and follow-up androgen panels. Absolute contraindications in women: pregnancy, lactation, hormone-sensitive cancer (breast, ovarian, endometrial), pregnancy planning, menstrual irregularity of unknown cause, any of the general contraindications (liver/kidney disease, etc.). For female sexual desire concerns specifically, Maca and Tribulus have better evidence bases than Fadogia for women.

Fadogia agrestis itself is not specifically listed on the WADA (World Anti-Doping Agency) Prohibited List as of current publications. However, athletes subject to drug testing should be cautious for three reasons: (1) Adulteration risk: Like many testosterone-marketed supplements, Fadogia products may be contaminated with actual anabolic-androgenic steroids, prohormones, or other banned substances. Testing positive on a WADA or similar panel due to supplement contamination is considered 'strict liability' — the athlete is responsible regardless of knowing contamination occurred. (2) Metabolite uncertainty: If Fadogia does produce significant testosterone elevation in humans, and metabolic patterns are analyzed, this could theoretically trigger abnormal endogenous steroid panels — though this is speculative without human data. (3) Evolving regulatory status: Banned substance lists update periodically; Fadogia could be added if sufficient evidence of performance enhancement emerges. Recommendations for tested athletes: Avoid Fadogia entirely unless you have documented NSF Certified for Sport or Informed Sport certification for the specific product and lot. Even then, recognize that certifications reduce but don't eliminate contamination risk. Most tested athletes would be better served by established, well-tested supplements (creatine, beta-alanine, citrulline, caffeine, protein, etc.) with lower contamination risk and stronger evidence bases for performance benefits.

That's a personal decision, but here's an honest framework: Reasons it might be reasonable to try: (1) You've already optimized evidence-based foundations (sleep, training, zinc, vitamin D, Tongkat Ali, ashwagandha) and want to experiment further; (2) You have the budget for quality Fadogia products plus baseline and follow-up labs; (3) You're willing to cycle strictly, monitor for adverse effects, and discontinue based on data not just hope; (4) You understand you're participating in informal self-experimentation rather than using a well-characterized supplement; (5) You don't have contraindications (liver/kidney disease, hormone-sensitive cancers, pregnancy, etc.); (6) You're not subject to drug testing. Reasons it's probably not worth trying: (1) You haven't optimized lifestyle and evidence-based supplements first; (2) You're expecting dramatic results (unlikely even if it works); (3) You're unwilling to do labs or monitor adverse effects; (4) You have any conditions that would make adverse effects particularly risky; (5) Budget is limited — spend it on proven supplements instead; (6) You're subject to drug testing; (7) You're pursuing conception or pregnancy in the foreseeable future. Honest positioning: Fadogia sits in the 'experimental tier' of supplements — not the evidence-based tier. It's in the same category as many compounds that turned out to be disappointing after initial enthusiasm (tribulus, deer antler velvet, D-aspartic acid, etc.) and a few that turned out to be meaningfully useful. For users interested in experimenting, doing so thoughtfully (cycling, monitoring, realistic expectations) produces more informative personal data than either blindly adopting the podcast enthusiasm or dismissively ignoring it.